DROXIA 300 DROXIA 300 Pill - purple capsule/oblong, 19mm
Generic Name: hydroxyurea
Pill with imprint DROXIA 300 DROXIA 300 is Purple, Capsule/Oblong and has been identified as Droxia 300 mg.
Droxia is used in the treatment of Sickle Cell Anemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 300 DROXIA 300
Droxia
- Generic Name
- hydroxyurea
- Imprint
- DROXIA 300 DROXIA 300
- Strength
- 300 mg
- Color
- Purple
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- H2-Pharma LLC
- National Drug Code (NDC)
- 61269-0403
More about Droxia (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Hydrea, Siklos, Mylocel, Xromi
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
